Simcha Therapeutics

Pioneering Transformational Immunotherapies

New Haven, United States · $65.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$65.0M
Last Round
$40.0M Series BJan 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Simcha Therapeutics is a clinical-stage immunobiology company pioneering the development of first-in-class engineered cytokine therapeutics for cancer. The company's name derives from the Hebrew word for joy, reflecting its mission to advance medicines that bring hope to patients with cancer. Simcha focuses on transforming fundamental discoveries in immune biology into innovative drugs that promise more than incremental advances.

Summary

Simcha Therapeutics is a Biotech company based in New Haven, United States. It has raised $65.0M in total across 2 rounds, most recently a $40.0M Series B round in Jan 2022. Investors include SR One, BVF Partners and Samsara BioCapital.

Funding History

Series BSeries BJan 2022
$40.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Simcha Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/simcha-therapeutics"><img src="https://indexed.vc/api/badge/company/simcha-therapeutics" alt="Simcha Therapeutics on Indexed.vc" width="260" height="76" /></a>